Rubius Therapeutics Taps Dannielle Appelhans as Chief Operating Officer
July 29 2021 - 9:12AM
Dow Jones News
By Robb M. Stewart
Rubius Therapeutics Inc. Thursday named Dannielle Appelhans as
chief operating officer to oversee corporate strategy and technical
operations.
The appointment is effective Aug. 9, the clinical-stage
biopharmaceutical company said.
Most recently, Ms. Appelhans was senior vice president of
technical operations and chief technical officer at Novartis Gene
Therapies, where she oversaw late-stage development, clinical and
commercial manufacturing, supply chain and all supporting
operational functions for the gene therapy unit and AAV portfolio
Rubius. Prior to joining Novartis, she was a senior engagement
manager at McKinsey & Co. in its pharmaceutical operations
practice, and earlier in her career she held roles at Eli Lilly
& Co.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
July 29, 2021 09:06 ET (13:06 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Novartis (NYSE:NVS)
Historical Stock Chart
From Mar 2024 to Apr 2024
Novartis (NYSE:NVS)
Historical Stock Chart
From Apr 2023 to Apr 2024
